| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Scleroderma, Diffuse; Scleroderma, Systemic; Sclerosis | Phase 2 | ClinicalTrials |
| Fatty Liver; Non-alcoholic Fatty Liver Disease | Phase 2 | ClinicalTrials |
CONTENTS